In addition, IL-1 beta has been associated with the pathogenesis of IBD, especially CD (39), and in experimental IBD, IL-1 beta has been shown to induce an increase in intestinal permeability in association with NF-kappa B activation (59). This evidence concerns the gene IL1B and inflammatory bowel disease.